Discovery of blood-brain barrier permeable and orally bioavailable caffeine-based amide derivatives as acetylcholinesterase inhibitors-Reference-Cited by-同舟云学术

Discovery of blood-brain barrier permeable and orally bioavailable caffeine-based amide derivatives as acetylcholinesterase inhibitors

Published:2023-10 Issue: Volume:139 Page:106719
ISSN:0045-2068
Container-title:Bioorganic Chemistry
language:en
Short-container-title:Bioorganic Chemistry

Author:

Sharma Mohit,Sharma Ankita,Thakur Shikha,Nuthakki Vijay K.,Jamwal Ashiya,Nandi Utpal,Jadhav Hemant R.,Bharate Sandip B.

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Molecular Biology,Biochemistry

Reference31 articles.

1. Alzheimer's disease – the journey of a healthy brain into organ failure;Golde;Mol. Neurodegener.,2022

2. 2021 Alzheimer's disease facts and figures, Alzheimers Dement. 17(3) (2021) 327-406.

3. The amyloid hypothesis in Alzheimer disease: new insights from new therapeutics;Karran;Nat. Rev. Drug Discov.,2022

4. Design, synthesis, and biological evaluation of new thalidomide–donepezil hybrids as neuroprotective agents targeting cholinesterases and neuroinflammation, RSC;Cristancho Ortiz;Med. Chem.,2022

5. Hypothesis: Tau pathology is an initiating factor in sporadic Alzheimer's disease;Arnsten;Alzheimers. Dement.,2021

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development of erythrina-based PARP-1/FTase dual-target inhibitors against lung cancer epithelial-mesenchymal transition (EMT) in vivo and in vitro;Bioorganic Chemistry;2024-07

2. Practical Three-Component Regioselective Synthesis of Drug-Like 3-Aryl(or heteroaryl)-5,6-dihydrobenzo[h]cinnolines as Potential Non-Covalent Multi-Targeting Inhibitors To Combat Neurodegenerative Diseases;ACS Chemical Neuroscience;2024-04-22

3. New Multitarget Molecules Derived from Caffeine as Potentiators of the Cholinergic System;ACS Chemical Neuroscience;2024-02-26

4. Coffee and Alzheimer's disease;Progress in Brain Research;2024